Characterization of the Immune Response to PD-1 Blockade during Chemoradiotherapy for Head and Neck Squamous Cell Carcinoma

SIMPLE SUMMARY: Blockade of the PD-1/L1 interaction represents a breakthrough in the treatment for recurrent/metastatic head and neck squamous cell carcinoma (HNSCC). Clinical and translational research suggests that this interaction may play a role in immune evasion during chemoradiotherapy. Using...

Descripción completa

Detalles Bibliográficos
Autores principales: Callejas-Valera, Juan L., Vermeer, Daniel W., Lucido, Christopher T., Williamson, Caitlin, Killian, Marisela, Vermeer, Paola D., Spanos, William C., Powell, Steven F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139476/
https://www.ncbi.nlm.nih.gov/pubmed/35626103
http://dx.doi.org/10.3390/cancers14102499

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139476/
https://www.ncbi.nlm.nih.gov/pubmed/35626103
http://dx.doi.org/10.3390/cancers14102499

Ejemplares similares